Applied Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Applied Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Applied Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $206K, a 67.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $206K -$422K -67.2% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $328K -$415K -55.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $447K -$410K -47.8% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $510K -$460K -47.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $628K -$453K -41.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $743K -$447K -37.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $857K -$441K -34% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $970K -$434K -30.9% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.08M -$427K -28.3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.19M -$422K -26.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.3M -$414K -24.2% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.4M -$350K -20% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.51M -$341K -18.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.61M -$330K -17% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $1.71M -$323K -15.9% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.75M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.85M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $1.94M Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $2.04M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.